Cargando…
Targeting Leukemia Stem Cell-Niche Dynamics: A New Challenge in AML Treatment
One of the most urgent needs in AML is to improve the disease cure rate as relapse still occurs in 60–80% of patients. Recent evidence suggests that dismal clinical outcomes may be improved by a better definition of the tight interaction between the AML cell population and the bone marrow (BM) micro...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Hindawi
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6702816/ https://www.ncbi.nlm.nih.gov/pubmed/31485227 http://dx.doi.org/10.1155/2019/8323592 |